To describe long-term mortality rates and causes of death in CSDH patients compared to the general population, and to assess the association of frailty, measured by specific criteria, with mortality.
Key Findings:
CSDH has a 12-month mortality rate of 15-20%, comparable to certain cancers, indicating a significant health concern.
Frailty is associated with increased mortality in CSDH patients, suggesting a need for targeted interventions.
Long-term excess mortality risk in CSDH patients compared to the general population highlights the importance of addressing frailty.
Interpretation:
The findings suggest that frailty significantly contributes to the mortality risk in patients with CSDH, indicating a critical need for targeted interventions to improve patient outcomes.
Limitations:
Retrospective design may introduce bias and limit causality.
Frailty assessment based on limited criteria may not capture all aspects of frailty, potentially overlooking other risk factors.
Conclusion:
Addressing frailty in CSDH patients could be crucial in reducing mortality rates, underscoring the importance of comprehensive geriatric assessment and targeted interventions in this population.
by Jurre Blaauw, Bram Jacobs, Heleen M. den Hertog, Niels A. van der Gaag, Korné Jellema, Ruben Dammers, Kuan H. Kho, Rob J. M. Groen, Joukje van der Naalt, Hester F. Lingsma
